Free Trial

Omega Therapeutics (OMGA) Insider Trading & Ownership

Omega Therapeutics logo
$0.89 +0.03 (+3.60%)
(As of 12:43 PM ET)

Omega Therapeutics (NASDAQ:OMGA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.50%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$19.21 M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$400,000.00
Get OMGA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Omega Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OMGA Insider Buying and Selling by Quarter

Omega Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/1/2023Richard A YoungDirectorSell5,000$8.00$40,000.00  
4/6/2023Richard A YoungDirectorSell5,000$8.00$40,000.00  
3/17/2023Richard A YoungDirectorSell10,000$8.00$80,000.00  
2/27/2023Flagship Pioneering Inc.Major ShareholderBuy3,323,310$5.78$19,208,731.80  
1/10/2023Richard A YoungDirectorSell20,000$8.00$160,000.00  
9/14/2022Richard A YoungDirectorSell10,000$8.00$80,000.00  
(Data available from 1/1/2013 forward)

OMGA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Omega Therapeutics includes Flagship Pioneering Inc., and Richard A Young. Learn more on insiders at OMGA.

8.50% of Omega Therapeutics stock is owned by insiders. Learn more on OMGA's insider holdings.

The following insider purchased OMGA shares in the last 24 months: Flagship Pioneering Inc. ($19,208,731.80).

Insiders have purchased a total of 3,323,310 OMGA shares in the last 24 months for a total of $19,208,731.80 bought.

The following insider sold OMGA shares in the last 24 months: Richard A Young ($320,000.00).

Insiders have sold a total of 40,000 Omega Therapeutics shares in the last 24 months for a total of $320,000.00 sold.

Omega Therapeutics Key Executives

  • Mr. Mahesh Karande (Age 50)
    President, CEO & Board Director
    Compensation: $910.39k
  • Mr. Joshua Reed M.B.A. (Age 51)
    Chief Financial Officer
    Compensation: $659.39k
  • Dr. Yan Moore M.D. (Age 57)
    Chief Medical Officer
    Compensation: $738.34k
  • Dr. Thomas McCauley Ph.D. (Age 55)
    Chief Scientific Officer
    Compensation: $588.5k
  • Ms. Ling Zeng Esq. (Age 55)
    J.D., Chief Legal & Administrative Officer and Secretary
    Compensation: $519.36k
  • Mr. Anthony Mullin
    Chief People Officer
  • Ms. Barbara Y. Chan (Age 60)
    Senior Vice President of Finance
  • Mr. Charles O'Donnell Ph.D.
    VP and Head of Computational Genomics & Data Sciences


This page (NASDAQ:OMGA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners